<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03470051</url>
  </required_header>
  <id_info>
    <org_study_id>BR007</org_study_id>
    <nct_id>NCT03470051</nct_id>
  </id_info>
  <brief_title>Case Collection Study in the Evaluation of Doubling Time Rates in Non-Suspicious Breast Masses Using QT Ultrasound Technology</brief_title>
  <acronym>EVALUATE</acronym>
  <official_title>A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women With Non-suspicious Breast Masses to Correlate the Calculated Mass Doubling Time Using Quantitative Transmission Ultrasound (QT Ultrasound) With Mass Histology.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>QT Ultrasound LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>QT Ultrasound LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective case collection study to collect cases for subsequent statistical
      studies and future reader studies.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Breast mass doubling time change</measure>
    <time_frame>90 days</time_frame>
    <description>The change in calculated mass doubling time using Quantitative Transmission Ultrasound (QT Ultrasound) from baseline will be measured and compared to mass histology.</description>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Breast Fibroadenoma</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>QT Ultrasound</intervention_name>
    <description>All subjects will be asked to agree to an ultrasound-guided breast needle biopsy by a qualified radiologist experienced in this procedure.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Needle breast biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with a non-suspicious breast mass will be recruited.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female

          2. Age 18 or older

          3. Willing to receive QT Ultrasound Breast Scans

          4. Willing to undergo an ultrasound-guided needle breast biopsy after the follow-up QT
             Ultrasound Breast Scan

          5. Willing and able to provide Informed Consent prior to any research-related
             procedure(s)

          6. Have an identified solid non-suspicious breast mass

        Exclusion Criteria:

          1. Pregnancy

          2. Currently breastfeeding

          3. Magnetic material in the chest which in the judgement of the Principal Investigator
             would interfere or be impacted by the magnets utilized with the study device.

          4. Not willing to provide information for primary care physician

          5. History of breast cancer

          6. History of treated or untreated cancer of a non-breast origin

          7. Physical inability to tolerate the QT scan, i.e. inability to lie prone and still for
             up to 30 minutes at a time

          8. Open wounds, sores or skin rash present on the breast(s) or nipple discharge from the
             scanned breast(s)

          9. Breasts too large for scanner, i.e. bra size larger than DDD or inability to
             successfully &quot;fit&quot; breast after the subject is placed on scanner

         10. Body weight greater than 400 lbs. (180 kg)

         11. Concurrent disease or condition which in the judgment of the Principal Investigator
             disqualifies the subject from participating in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Subjects must be female</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajni Natesan, MD</last_name>
    <role>Study Director</role>
    <affiliation>Chief Medical Officer</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marin Breast Health Trial Center</last_name>
    <phone>(415) 842-7400</phone>
    <email>info@marinbreasthealth.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Marin Breast Health Trial Center</name>
      <address>
        <city>Novato</city>
        <state>California</state>
        <zip>94949</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Study Information</last_name>
      <phone>415-842-7400</phone>
      <email>info@marinbreasthealth.com</email>
    </contact>
    <investigator>
      <last_name>Lauralyn Markle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2018</study_first_submitted>
  <study_first_submitted_qc>March 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>March 16, 2018</last_update_submitted>
  <last_update_submitted_qc>March 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibroadenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

